Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study
长效SARS-CoV-2抗体Tixagevimab/Cilgavimab (AZD7442)重复给药的安全性和药代动力学:PROVENT子研究结果
期刊:Clinical Drug Investigation
影响因子:2.7
doi:10.1007/s40261-025-01515-x
Ustianowski, Andrew; Levin, Myron J; De Wit, Stephane; Launay, Odile; Veekmans, Bernard; Rampling, Tommy; Sullivan, James G; Vishnepolsky, Mark; Wijewardane, Priyantha; Fawadleh, Yousef; Zhang, Huixia; Li, Meng; Wickramarachchi, Dilki; Sharbaugh, Audrey; Beavon, Rohini; Thissen, Jesse; Hirao, Lauren; Dzutseva, Vitalina; Seegobin, Seth; Streicher, Katie; Kiazand, Alexandre; Esser, Mark T; Chang, Lee-Jah; Perez, John L; Cohen, Taylor S